Artemisinin Combination Therapy (ACT) Market Size, Share & Trends Analysis Report By Type (Artemether+Lumefantrine, Artesunate+Amodiaquine, Dihydroartemisinin+Piperaquine, Artesunate+Mefloquine, Artesunate+Sulfadoxine-Pyrimethamine, Pyronaridine-Artesunate, Other), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug Stores & Retail Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Tejas Zamde | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Artemisinin Combination Therapy (ACT) Market Size Analysis
    1. Introduction
    2. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Artemether+Lumefantrine
      2. Artesunate+Amodiaquine
      3. Dihydroartemisinin+Piperaquine
      4. Artesunate+Mefloquine
      5. Artesunate+Sulfadoxine-Pyrimethamine
      6. Pyronaridine-Artesunate
      7. Other
    3. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Drug Stores & Retail Pharmacies
  7. North America Artemisinin Combination Therapy (ACT) Market Size Analysis
    1. Introduction
    2. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Artemether+Lumefantrine
      2. Artesunate+Amodiaquine
      3. Dihydroartemisinin+Piperaquine
      4. Artesunate+Mefloquine
      5. Artesunate+Sulfadoxine-Pyrimethamine
      6. Pyronaridine-Artesunate
      7. Other
    3. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Drug Stores & Retail Pharmacies
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
  8. Europe Artemisinin Combination Therapy (ACT) Market Size Analysis
    1. Introduction
    2. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Artemether+Lumefantrine
      2. Artesunate+Amodiaquine
      3. Dihydroartemisinin+Piperaquine
      4. Artesunate+Mefloquine
      5. Artesunate+Sulfadoxine-Pyrimethamine
      6. Pyronaridine-Artesunate
      7. Other
    3. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Drug Stores & Retail Pharmacies
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    6. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
  9. APAC Artemisinin Combination Therapy (ACT) Market Size Analysis
    1. Introduction
    2. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Artemether+Lumefantrine
      2. Artesunate+Amodiaquine
      3. Dihydroartemisinin+Piperaquine
      4. Artesunate+Mefloquine
      5. Artesunate+Sulfadoxine-Pyrimethamine
      6. Pyronaridine-Artesunate
      7. Other
    3. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Drug Stores & Retail Pharmacies
    4. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
  10. Middle East and Africa Artemisinin Combination Therapy (ACT) Market Size Analysis
    1. Introduction
    2. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Artemether+Lumefantrine
      2. Artesunate+Amodiaquine
      3. Dihydroartemisinin+Piperaquine
      4. Artesunate+Mefloquine
      5. Artesunate+Sulfadoxine-Pyrimethamine
      6. Pyronaridine-Artesunate
      7. Other
    3. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Drug Stores & Retail Pharmacies
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
  11. LATAM Artemisinin Combination Therapy (ACT) Market Size Analysis
    1. Introduction
    2. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Artemether+Lumefantrine
      2. Artesunate+Amodiaquine
      3. Dihydroartemisinin+Piperaquine
      4. Artesunate+Mefloquine
      5. Artesunate+Sulfadoxine-Pyrimethamine
      6. Pyronaridine-Artesunate
      7. Other
    3. Artemisinin Combination Therapy (ACT) Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Drug Stores & Retail Pharmacies
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
  12. Competitive Landscape
    1. Artemisinin Combination Therapy (ACT) Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Sanofi
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. PATH
    3. KPC Pharmaceuticals, Inc
    4. Guilin Pharmaceutical Co., Ltd
    5. Calyx Chemicals and Pharmaceuticals Ltd.
    6. Novartis AG
    7. Ipca Laboratories Ltd.
    8. Cipla Inc.
    9. CO, LTD
    10. AdvaCare Pharma
    11. Ajanta Pharma Ltd.
    12. Mylan N.V.
    13. Strides Pharma Science Limited
    14. Zydus Cadila
    15. Ranbaxy Laboratories Limited
    16. Bayer AG
    17. GSK plc
    18. Pfizer Inc
    19. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Artemisinin Combination Therapy (ACT) Market Size and Forecast By Regions - 2022-2034 (USD Million)

Table 2: Global Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 3: Global Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 4: North America Artemisinin Combination Therapy (ACT) Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 5: North America Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 6: North America Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 7: U.S. Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 8: U.S. Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 9: Canada Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 10: Canada Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 11: Europe Artemisinin Combination Therapy (ACT) Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 12: Europe Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 13: Europe Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 14: U.K. Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 15: U.K. Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 16: Germany Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 17: Germany Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 18: France Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 19: France Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 20: Spain Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 21: Spain Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 22: Italy Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 23: Italy Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 24: Russia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 25: Russia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 26: Nordic Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 27: Nordic Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 28: Benelux Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 29: Benelux Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 30: Rest of Europe Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 31: Rest of Europe Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 32: APAC Artemisinin Combination Therapy (ACT) Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 33: APAC Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 34: APAC Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 35: China Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 36: China Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 37: Korea Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 38: Korea Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 39: Japan Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 40: Japan Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 41: India Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 42: India Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 43: Australia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 44: Australia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 45: Taiwan Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 46: Taiwan Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 47: South East Asia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 48: South East Asia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 49: Rest of Asia-Pacific Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 50: Rest of Asia-Pacific Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 51: Middle East and Africa Artemisinin Combination Therapy (ACT) Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 52: Middle East and Africa Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 53: Middle East and Africa Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 54: UAE Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 55: UAE Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 56: Turkey Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 57: Turkey Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 58: Saudi Arabia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 59: Saudi Arabia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 60: South Africa Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 61: South Africa Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 62: Egypt Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 63: Egypt Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 64: Nigeria Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 65: Nigeria Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 66: Rest of MEA Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 67: Rest of MEA Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 68: LATAM Artemisinin Combination Therapy (ACT) Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 69: LATAM Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 70: LATAM Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 71: Brazil Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 72: Brazil Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 73: Mexico Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 74: Mexico Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 75: Argentina Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 76: Argentina Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 77: Chile Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 78: Chile Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 79: Colombia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 80: Colombia Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 81: Rest of LATAM Artemisinin Combination Therapy (ACT) Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 82: Rest of LATAM Artemisinin Combination Therapy (ACT) Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

We are featured on: